Health
Study shows mRNA-1273 vaccine can prevent symptomatic COVID-19 infection – News-Medical.Net
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine…
A peer-reviewed paper published in The New England Journal of Medicine provides data from the much-anticipated COVE study, which evaluated mRNA-1273, a vaccine candidate against COVID-19 manufactured by Moderna, Inc.
Results from the primary analysis of the study, which will continue for two years, provide evidence that the vaccine can prevent symptomatic infection.
Among the more than 30,000 participants randomized to receive the vaccine or a placebo, 11 of those in the vaccine group developed…
-
General22 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
Noosa News23 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
Noosa News8 hours agoNSW farmer calls for hunting buffer zones after bullets hit property
-
General17 hours agoAlbo and Dutton do battle for the Port of Darwin